IDEAYA Biosciences, Inc.
IDYA
$30.24
$0.391.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.76% | -115.82% | -138.25% | -142.98% | -72.59% |
| Total Depreciation and Amortization | -4.18% | -4.92% | -5.93% | -4.34% | 7.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 286.97% | 318.44% | 271.98% | 65.99% | 0.05% |
| Change in Net Operating Assets | 46.69% | -23.77% | 287.42% | 187.42% | 169.90% |
| Cash from Operations | 31.68% | -124.86% | -101.31% | -114.87% | -30.33% |
| Capital Expenditure | 12.69% | 5.00% | -5.81% | -62.88% | -134.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.60% | 74.33% | 87.81% | -219.50% | -648.84% |
| Cash from Investing | 92.91% | 73.58% | 87.17% | -217.16% | -634.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.20% | -44.14% | -48.23% | 108.45% | 327.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 33.33% | -77.72% | -77.72% | -53.18% |
| Cash from Financing | -96.27% | -43.16% | -49.98% | 86.80% | 267.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.81% | -185.22% | -48.04% | -181.53% | 392.20% |